By Sabela Ojea
Personalis Inc. said Monday it sued Foresight Diagnostics for allegedly infringing three patents, months after suing the same company over four additional patents.
The precision oncology company said Foresight Diagnostics improperly based its solid tumor minimal residual disease approach on technology already patented by Personalis.
The company seeks injunctive relief and monetary damages.
In August, Personalis said it filed a lawsuit against Foresight for allegedly infringing three patents related to its intellectual property portfolio in the field of whole genome-enabled, tumor-informed molecular residual disease testing.
Write to Sabela Ojea at [email protected]
Read the full article here
